Assistant Professor @MacAnesthesia @HEI_McMaster. Health Research Methodologist/ Epidemiologist. Former @CIHR_IRSC Banting Fellow @HarvardDBMI 🇨🇦👩🏻‍💻

Joined November 2015
🎙️Ecstatic to share a podcast interview with @drjohnm from @Sensible__Med about analytic flexibility and nutritional epidemiology.🍎🥩 Hear the podcast: sensible-med.com/p/a-discuss… Read the paper: linkinghub.elsevier.com/retr… @MacAnesthesia @HEI_mcmaster @machealthsci
You all. I found a beautiful study to write about @Sensible__Med. A new way to analyze observational studies. Gosh, I am excited. Not only to find this study but also to talk with senior author @DenaZera Post here sensible-med.com/p/the-defin… Podcast tomorrow.
4
5
3
35
7,370
Dena Zeraatkar retweeted
Our @BMJMedicine network meta-analysis (151 trials) found no moderate or high-certainty evidence that any drug provides important benefits for fibromyalgia. Some drugs may help some patients - evidence is low certainty and benefits are typically small:bmjmedicine.bmj.com/content/…
6
10
436
Dena Zeraatkar retweeted
Grilling the data: application of specification curve analysis to red meat and all-cause mortality jclinepi.com/article/S0895-4… via @DenaZera et al & The Definitive Analysis of Observational Studies sensible-med.com/p/the-defin… via @drjohnm
3
3
692
Dena Zeraatkar retweeted
A systematic review takes one to two years. Very little of that time goes to thinking. It goes to moving citations between disconnected tools. We built CoreSR to strip that out and return the reviewer's time to judgment. youtube.com/@CoreSR coresr.ai/
8
58
2
233
29,380
Weeks of manual synthesis reduced to less than 10 minutes. Watch how CoreSR runs a Bayesian NMA + automated GRADE assessment instantly. Watch below 👇 #EvidenceBasedMedicine @GuyattGH @Bram_Rochwerg @DenaZera Vist Coresr.ai
4
5
529
"A significant fraction of the reporters covering the FDA and pharmaceutical industry have developed, over years of access journalism, a set of relationships and sympathies that align them more closely with the companies they cover than with the regulatory mission"
3
12
1
55
5,946
👁️ Our editorial outlines how ophthalmologists, researchers, and guideline developers can use the GRADE evidence-to-decision (EtD) and the GRADE-Adolopment to create trustworthy clinical practice guidelines. 🔗 Full editorial: nature.com/articles/s41433-0…
1
1
154
🚨📢 Postdoc opening @EmoryEPI in pharmaceutical regulation, evidence synthesis & meta-research. 1-year position w/ possible renewal. Formal posting coming soon—message or email me for details. Please share! @Yale_CRRIT @METRICStanford @NaudetFlorian @RoRInstitute @jsross119
2
5
10
1,855
Super proud of @TylerSC10 ! Amazing work! ⭐️
🚨 Excited to share our new paper in @LancetRespirMed 🚨 Our systematic review & network meta-analysis compares preoxygenation strategies for critically ill patients needing intubation. NIPPV tops HFNC & facemask in reducing hypoxaemia. 🔍 Study Highlights • Systematic review & network meta-analysis of 15 RCTs (n=3420) • Compared HFNC, NIPPV, and facemask oxygen for preoxygenation • NIPPV likely best at reducing hypoxaemia during intubation   – vs HFNC: RR 0.73 (moderate certainty)   – vs facemask: RR 0.51 (high certainty) • HFNC better than facemask: RR 0.69 (high certainty) • No strategy improved first-attempt intubation success • NIPPV may reduce serious adverse events vs HFNC/facemask • No clear mortality difference between methods • Data used to inform upcoming international airway guidelines 🧠 Implications: NIPPV may be preferred in high-risk or critically ill patients; findings support evidence-based guideline updates kwnsfk27.r.eu-west-1.awstrac… @UofT_DoM @MacDeptMed @Bram_Rochwerg @DenaZera @HEI_mcmaster
1
6
716
Dena Zeraatkar retweeted
🚨 New Clinical Guidelines Alert 🚨 A major review recommends against commonly used interventional procedures like epidural injections, nerve blocks & ablations for chronic spine pain Why? ❌ Similar benefits to sham, potential risks, & high costs bmj.com/content/388/bmj-2024…
1
6
1
17
1,219
Dena Zeraatkar retweeted
Face Masking and Risk of Post-Intravitreal Injection Endophthalmitis: A Network Meta-Analysis of 2.6 Million Injections ow.ly/xvqa50UpUn0 @UofTDOVS @brendantao @RSTHuang @AndrewMihalache @DenaZera @PopovicMM @Jim_SCX @kztoronto @RKohly @RaHMu123
9
1
14
2,997
Enroll now! New term starts January 20th, 2025! #macanesthesia
1
1
329
Dena Zeraatkar retweeted
What leads us to ignore experts isn't their knowledge. It's their arrogance. Evidence: Scientists are more credible when they admit what they don't know, acknowledge what they got wrong, and update their views. Trust is earned by expressing humility, not by asserting authority.
129
877
135
3,635
397,784
Dena Zeraatkar retweeted
🇨🇦 A recent webinar explored how @AMMICanada, @GovCanHealth and @Firstline are partnering to develop evidence-based national antimicrobial prescribing guidelines. We’re proud to work with these incredible teams, including the AMMI Guidelines Panel: Chair: Dr. @deb_yamamura, Dr. @DenaZera Dr. Mark Loeb, Dr. Nicole Le Saux, Dr. Peter Daley, Dr. @rwittmer3 , Dr. @ATseChangMD , Dr. @BRxAD , Dr. Philippe Morency-Potvin, Dr. Kevin Afra, Dr. Alyssa Ness and Dr. @TimLauRx . View the full presentation slides here: tinyurl.com/5f93wfv9
2
6
419
Check out the latest publication from the NPC: Interventions for the management of long covid (post-covid condition): living systematic review bmj.com/content/387/bmj-2024…
1
3
8
928